Evidence map›Paper›PMID 27781145›Full record

ArticleBrain and behavior2016

The feasibility of

Kei Sasaki, Norihide Maikusa, Etsuko Imabayashi, Tetsuya Yuasa, Hiroshi Matsuda

Abstract readValidation Study
In one paragraph

Article in Brain and behavior, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. The feasibility ofBrain and behavior · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kei SasakiGraduate School of Science and Engineering Yamagata University Yamagata Japan; Integrative Brain Imaging Center National Center of Neurology and Psychiatry Kodaira Tokyo Japan; Department of Nuclear Medicine Saitama Medical University International Medical Center Saitama Japan.
Norihide MaikusaIntegrative Brain Imaging Center National Center of Neurology and Psychiatry Kodaira Tokyo Japan.
Etsuko ImabayashiIntegrative Brain Imaging Center National Center of Neurology and Psychiatry Kodaira Tokyo Japan.
Tetsuya YuasaGraduate School of Science and Engineering Yamagata University Yamagata Japan.
Hiroshi MatsudaIntegrative Brain Imaging Center National Center of Neurology and Psychiatry Kodaira Tokyo Japan; Department of Nuclear Medicine Saitama Medical University International Medical Center Saitama Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAmyloid positron-emission tomography (PET) imaging with

methodsWe investigated the feasibility of correcting PVE in amyloid PET using CT, obtained by PET/CT, instead of MRI. We demonstrated the efficacy of partial volume correction (PVC) based on CT by comparing the results of CT-based PVC and those of MRI-based PVC using images acquired from AD patients and controls.

resultsBoth methods were able to perform PVC. Slight but significant differences between standard uptake volume ratio (SUVR) values were noted between the two modalities; these were attenuated by constant multiplication.

conclusionCT will potentially replace MRI for PVC, allowing the use of a single PET/CT scanner for amyloid plaque quantitation.

Indexed as

BenzothiazolesRadiopharmaceuticalsAgedAlzheimer DiseaseAniline CompoundsBrainBrain MappingFeasibility StudiesFemaleHumansMagnetic Resonance ImagingMalePlaque, AmyloidPositron Emission Tomography Computed TomographyThiazoles2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazoleAniline CompoundsBenzothiazolesRadiopharmaceuticalsThiazolesAlzheimer diseaseamyloid plaques/RImagnetic resonance imagingmultidetector computed tomographypositron‐emission tomography/MT

Identifiers

PMID27781145
PMCPMC5064343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.